PMID- 22586495 OWN - NLM STAT- MEDLINE DCOM- 20120926 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 7 IP - 5 DP - 2012 TI - Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosis. PG - e36779 LID - 10.1371/journal.pone.0036779 [doi] LID - e36779 AB - Multiple sclerosis (MS) is a complex disease of the central nervous system of unknown etiology. The human leukocyte antigen (HLA) locus on chromosome 6 confers a considerable part of the susceptibility to MS, and the most important factor is the class II allele HLA-DRB1*15:01. In addition, we and others have previously established a protective effect of HLA-A*02. Here, we genotyped 1,784 patients and 1,660 healthy controls from Scandinavia for the HLA-A, HLA-B, HLA-C and HLA-DRB1 genes and investigated their effects on MS risk by logistic regression. Several allele groups were found to exert effects independently of DRB1*15 and A*02, in particular DRB1*01 (OR = 0.82, p = 0.034) and B*12 (including B*44/45, OR = 0.76, p = 0.0028), confirming previous reports. Furthermore, we observed interaction between allele groups: DRB1*15 and DRB1*01 (multiplicative: OR = 0.54, p = 0.0041; additive: AP = 0.47, p = 4 x 10(-06)), DRB1*15 and C*12 (multiplicative: OR = 0.37, p = 0.00035; additive: AP = 0.58, p = 2.6 x 10(-05)), indicating that the effect size of these allele groups varies when taking DRB1*15 into account. Analysis of inferred haplotypes showed that almost all DRB1*15 bearing haplotypes were risk haplotypes, and that all A*02 bearing haplotypes were protective as long as they did not carry DRB1*15. In contrast, we found one class I haplotype, carrying A*02-C*05-B*12, which abolished the risk of DRB1*15. In conclusion, these results confirms a complex role of HLA class I and II genes that goes beyond DRB1*15 and A*02, in particular by including all three classical HLA class I genes as well as functional interactions between DRB1*15 and several alleles of DRB1 and class I genes. FAU - Link, Jenny AU - Link J AD - Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. jenny.link@ki.se FAU - Kockum, Ingrid AU - Kockum I FAU - Lorentzen, Aslaug R AU - Lorentzen AR FAU - Lie, Benedicte A AU - Lie BA FAU - Celius, Elisabeth G AU - Celius EG FAU - Westerlind, Helga AU - Westerlind H FAU - Schaffer, Marie AU - Schaffer M FAU - Alfredsson, Lars AU - Alfredsson L FAU - Olsson, Tomas AU - Olsson T FAU - Brynedal, Boel AU - Brynedal B FAU - Harbo, Hanne F AU - Harbo HF FAU - Hillert, Jan AU - Hillert J LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120507 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (HLA-A Antigens) RN - 0 (HLA-B Antigens) RN - 0 (HLA-DRB1 Chains) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Alleles MH - Female MH - Genetic Association Studies MH - Genetic Predisposition to Disease MH - *HLA-A Antigens/genetics MH - *HLA-B Antigens/genetics MH - HLA-DRB1 Chains/*genetics MH - Haplotypes MH - Humans MH - Linkage Disequilibrium MH - Male MH - Middle Aged MH - Multiple Sclerosis/*genetics MH - Polymorphism, Single Nucleotide MH - Scandinavian and Nordic Countries PMC - PMC3346735 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2012/05/16 06:00 MHDA- 2012/09/27 06:00 PMCR- 2012/05/07 CRDT- 2012/05/16 06:00 PHST- 2011/08/01 00:00 [received] PHST- 2012/04/06 00:00 [accepted] PHST- 2012/05/16 06:00 [entrez] PHST- 2012/05/16 06:00 [pubmed] PHST- 2012/09/27 06:00 [medline] PHST- 2012/05/07 00:00 [pmc-release] AID - PONE-D-11-15207 [pii] AID - 10.1371/journal.pone.0036779 [doi] PST - ppublish SO - PLoS One. 2012;7(5):e36779. doi: 10.1371/journal.pone.0036779. Epub 2012 May 7.